Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan Renmin Hospital, Shiyan, 442000, Hubei Province, People's Republic of China.
Department of Neurology, The Affiliated Hospital of Guangdong Medical University, and Institute of Neurology, Guangdong Medical University, Zhanjiang, Guangdong Province, People's Republic of China.
Metab Brain Dis. 2017 Oct;32(5):1323-1334. doi: 10.1007/s11011-017-0050-0. Epub 2017 Jun 21.
Insulin resistance often refers to a pathological condition in which cells fail to respond to the normal actions of insulin. Increasing literature has noted a critical role of insulin resistance in the pathogenesis of ischemic stroke. Insulin resistance plays an important role in the pathogenesis of ischemic stroke via enhancing advanced changes of atherosclerosis. A variety of literature indicates that insulin resistance enhances platelet adhesion, activation and aggregation which are conducive to the occurrence of ischemic stroke. Insulin resistance also induces hemodynamic disturbances and contributes to the onset of ischemic stroke. In addition, insulin resistance may augment the role of the modifiable risk factors in ischemic stroke and induce the occurrence of ischemic stroke. Preclinical and clinical studies have supported that improving insulin resistance may be an effective measure to prevent or delay ischemic stroke.
胰岛素抵抗通常是指细胞对胰岛素的正常作用反应丧失的一种病理状态。越来越多的文献指出,胰岛素抵抗在缺血性卒中的发病机制中起关键作用。胰岛素抵抗通过增强动脉粥样硬化的晚期变化,在缺血性卒中的发病机制中起重要作用。多种文献表明,胰岛素抵抗增强了血小板的黏附、激活和聚集,有利于缺血性卒中的发生。胰岛素抵抗还会引起血流动力学紊乱,导致缺血性卒中的发作。此外,胰岛素抵抗可能增强缺血性卒中的可改变危险因素的作用,并导致缺血性卒中的发生。临床前和临床研究支持改善胰岛素抵抗可能是预防或延迟缺血性卒中的有效措施。